Cargando…

Predictive factors for alpha blocker use after transurethral prostatectomy: Can preoperative urodynamic outcome predict alpha blocker medication after surgery?

OBJECTIVE: To analyze the diagnostic value of conducting urodynamic study (UDS) and show predictors for alpha blocker use 12 months after transurethral prostatectomy. MATERIALS AND METHODS: Our study includes 406 participants that had a transurethral prostatectomy at our hospital between 2010 and 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sung Jin, Park, Sung Gon, Pak, Sahyun, Lee, Young Goo, Cho, Sung Tae, Kwon, Ohseong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491595/ https://www.ncbi.nlm.nih.gov/pubmed/36129917 http://dx.doi.org/10.1371/journal.pone.0274399

Ejemplares similares

Alpha–blocker and apoptosis
por: Elterman, Dean S., et al.
Publicado: (2013)

Preoperative Factors Predictive of Continence Recovery after Radical Retropubic Prostatectomy
por: Lim, Tae Joon, et al.
Publicado: (2012)

Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes
por: Kwon, Ohseong, et al.
Publicado: (2014)

Preoperative Factors Predictive of Posterolateral Extracapsular Extension After Radical Prostatectomy
por: Pak, Sahyun, et al.
Publicado: (2013)

The Role of Alpha Blockers in Children with Dysfunctional Voiding
por: Austin, Paul F.
Publicado: (2009)

Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms
por: Shim, Kang Hee, et al.
Publicado: (2018)

Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson's disease
por: Gomes, Cristiano M, et al.
Publicado: (2014)

Effect of alpha1-blockers on stentless ureteroscopic lithotripsy
por: Zhu, Jianguo, et al.
Publicado: (2016)

The Relationship Between Nocturia and Mortality: Data From the National Health and Nutrition Examination Survey
por: Moon, Shinje, et al.
Publicado: (2022)

The influence of preoperative urodynamic parameters on clinical results in patients with benign prostatic hyperplasia after transurethral resection of the prostate
por: Yang, Jiyao, et al.
Publicado: (2023)

Is prostatic artery embolization a relevant treatment after a failed alpha-blocker monotherapy?
por: Lebdai, Souhil
Publicado: (2023)

Use of Anti-TNF Alpha Blockers Can Reduce Operation Rate and Lead to Growth Gain in Pediatric Crohn's Disease
por: Woo, Min Hyung, et al.
Publicado: (2019)

Prescription pattern of alpha-blockers for management of lower urinary tract symptoms/benign prostatic hyperplasia
por: Moon, Hyong Woo, et al.
Publicado: (2018)

Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis
por: Hollingsworth, John M, et al.
Publicado: (2016)

A prospective pilotstudy comparing the anesthetic effects of an alpha-2 agonist during holmium laser resection of the prostate and transurethral resection for prostate surgery for benign prostatic hyperplasia patients using selective alpha-1 blockers
por: Lee, Do-Won, et al.
Publicado: (2018)

Efficacy of Alpha Blocker Treatment According to the Degree of Intravesical Prostatic Protrusion Detected by Transrectal Ultrasonography in Patients with Benign Prostatic Hyperplasia
por: Park, Hee Young, et al.
Publicado: (2012)

Alpha-Blocker Treatment Response in Men With Lower Urinary Tract Symptoms Based on Sympathetic Activity: Prospective, Multicenter, Open-Labeled, Observational Study
por: Park, Sung Gon, et al.
Publicado: (2015)

Is prostatic artery embolization a relevant treatment after a failed alpha-blocker monotherapy?—Authors’ reply
por: Sapoval, Marc, et al.
Publicado: (2023)

α-Blocker Monotherapy and α-Blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years' Long-Term Results
por: Shin, Teak Jun, et al.
Publicado: (2012)

Prospective Factor Analysis of Alpha Blocker Monotherapy Failure in Benign Prostatic Hyperplasia
por: Hong, Kyoung Pyo, et al.
Publicado: (2010)

Comparison of Alpha Blockers in Treatment of Premature Ejaculation: A Pilot Clinical Trial
por: Akin, Yigit, et al.
Publicado: (2013)

Complications of cataract surgery in patients with BPH treated with alpha 1A-blockers
por: Jan Teper, Slawomir, et al.
Publicado: (2011)

Analyses of the Mode of Action of an Alpha-Adrenoceptor Blocker in Substantia Gelatinosa Neurons in Rats
por: Uta, Daisuke, et al.
Publicado: (2021)

Alpha-Blocker Prescribing Trends for Ureteral Stones: A Single-Centre Study
por: Qu, Liang G, et al.
Publicado: (2022)

Efficacy of an Alpha-Blocker for the Treatment of Nonneurogenic Voiding Dysfunction in Women: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Lee, Young-Suk, et al.
Publicado: (2018)

Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based study in Taiwan
por: Sung, Shian-Ying, et al.
Publicado: (2020)

Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments
por: Kang, Dong Hyuk, et al.
Publicado: (2011)

Risk of intraoperative floppy iris syndrome among selective alpha-1 blockers—A consistency model of 6,488 cases
por: Wang, Ya-Hui, et al.
Publicado: (2022)

The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project
por: Leeb, Burkhard F., et al.
Publicado: (2009)

Effects of Tumor Necrosis Factor Alpha Blocker Adalimumab in Experimental Spinal Cord Injury
por: Börcek, Alp Özgün, et al.
Publicado: (2015)

Patients’ Attitudes Towards Deprescribing Alpha-Blockers and Their Willingness to Participate in a Discontinuation Trial
por: Edelman, Malou, et al.
Publicado: (2019)

Prospective evaluation of an intraoperative urodynamic stress test predicting urinary incontinence after robot-assisted laparoscopic radical prostatectomy
por: Mohr, Mirjam Naomi, et al.
Publicado: (2023)

Prolonged paradoxical reaction to anti-tuberculous treatment after discontinuation of TNF-alpha- blocker therapy with adalimumab. Rare clinical documentation
por: Falkenstern-Ge, Roger Fei, et al.
Publicado: (2014)

Changes in health-related quality of life after radical prostatectomy for prostate cancer: A longitudinal cohort study in Korea
por: Pak, Sahyun, et al.
Publicado: (2018)

Bladder Wall Thickness is Associated with Responsiveness of Storage Symptoms to Alpha-Blockers in Men with Lower Urinary Tract Symptoms
por: Park, Jung Soo, et al.
Publicado: (2012)

An Evaluation of the Efficacy of Selective Alpha-Blockers in the Treatment of Children with Neurogenic Bladder Dysfunction—Preliminary Findings
por: Kroll, Paweł, et al.
Publicado: (2016)

Risk of Hip Fractures in Men with Alpha-Blockers: A Nationwide Study Base on Claim Registry
por: Seo, Gi-Hyeon, et al.
Publicado: (2015)

Intravescical prostatic protrusion is a predictor of alpha blockers response: results from an observational study
por: Topazio, L., et al.
Publicado: (2018)

Evaluation of apoptosis indexes in currently used oral alpha- blockers in prostate: a pilot study
por: Demir, Mehmet, et al.
Publicado: (2018)

Evaluation of ultrasonographic predictors of alpha-blocker mono-therapy failure in symptomatic benign prostatic enlargement
por: Radwan, Mohamed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4nekjtf10rq8f9nvpjh3tglob1